Skip to main content

Table 1 Demographics and clinical characteristics of the 123 patients recruited

From: Efficacy and safety of modified medium-chain triglyceride ketogenic diet in patients with drug-resistant epilepsy

 

Median/ Number

25th percentile,75th percentile/ Percentage

Age (years)

14.8

9.0, 25.9

Male sex

73

59.3%

Age of epilepsy onset (years)

7.0

2.0, 15.0

Disease duration (years)

6.4

2.5, 10.9

Monthly seizure frequency

 1–10

72

58.5%

 11–50

12

9.8%

 51–100

22

17.9%

  > 100

17

13.8%

Epilepsy type

 Focal epilepsy

86

69.9%

 Generalized epilepsy

6

4.9%

 Unknown

31

25.2%

Syndrome

 IESS

9

7.3%

 LGS

3

2.4%

 Dravet syndrome

2

1.6%

 Hypothalamic hamartoma

1

0.8%

 Rasmussen syndrome

1

0.8%

Medication usage

 2

51

41.5%

 3

40

32.5%

 4

25

20.3%

 5 or more

7

5.7%